Reaching C-Reactive Protein and Low-Density Lipoprotein Cholesterol Goals in Dyslipidemic Patients (from the Lipid Treatment Assessment Project [L-TAP] 2)-Reference-Cited by-同舟云学术

Reaching C-Reactive Protein and Low-Density Lipoprotein Cholesterol Goals in Dyslipidemic Patients (from the Lipid Treatment Assessment Project [L-TAP] 2)

Published:2011-06 Issue:11 Volume:107 Page:1639-1643
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Chiang Cheng-Wen,Santos Raul D.,Waters David D.,Messig Michael,Tarasenko Lisa,Jukema J. Wouter,Ferrières Jean,Foody JoAnne,Seung Ki-Bae

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals;Waters;Circulation,2009

2. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;Circulation,2002

3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;J Am Coll Cardiol,2004

4. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (<70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study);Betteridge;Am J Cardiol,2007

5. Comparative effects of 10-mg versus 80-mg atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study;Bonnet;Clin Ther,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rate of patients at high risk for cardiovascular disease with an optimal low-density cholesterol level: a multicenter study from Thailand;J GERIATR CARDIOL;2019

2. Statin combination therapy and cardiovascular risk reduction;Future Cardiology;2016-05

3. Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia;Lipids in Health and Disease;2015-09-13

4. Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients;Atherosclerosis;2015-06

5. Some molecular targets for antihyperlipidemic drug research;European Journal of Medicinal Chemistry;2014-10